Biblio

Export 7 results:

Tekijä Otsikko [ Tyyppi

Suodattimet: Tekijä is Rauniyar, Khushbu [Clear All Filters]

Journal Article

Rauniyar K, Akhondzadeh S, Gąciarz A, Künnapuu J, Jeltsch M. Bioactive VEGF-C from E. coli. Scientific Reports [Internet]. 2022;12(1). https://www.nature.com/articles/s41598-022-22960-0

Rauniyar et al. - 2022 - Bioactive VEGF-C from E. coli (4.19 MB)

Biomass-derived Lignin Nanoparticles for the Sustained Delivery of Vascular Endothelial Growth Factor-C. Molecular Pharmaceutics. Submitted;.

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Scientific Reports [Internet]. 2017;7(1):4916. https://www.nature.com/articles/s41598-017-04982-1

Rauniyar K, Bokharaie H, Jeltsch M. Expansion and collapse of VEGF diversity in major clades of the animal kingdom. Angiogenesis [Internet]. 2023;26(3):437 - 461. https://link.springer.com/10.1007/s10456-023-09874-9

Rauniyar et al. - 2023 - Expansion and collapse of VEGF diversity in major clades of the animal kingdom (3.59 MB)

Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase. Scientific Reports [Internet]. 2024;14(1):26085. https://www.nature.com/articles/s41598-024-77104-3

Jha SK, Rauniyar K, Chronowska E, Mattonet K, Maina EW, Koistinen H, ym.. KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. eLife [Internet]. 2019;8:e44478. https://elifesciences.org/articles/44478

Jha & Rauniyar et al. 2019 (3.84 MB)

Thesis

Rauniyar K. VEGF-C: The evolutionary origin, activation, and potential as a drug target [Internet]. [Helsinki. Finland]: University of Helsinki; 2023. http://hdl.handle.net/10138/357923

Rauniyar - 2023 - VEGF-C: The evolutionary origin, activation, and potential as a drug target (3.09 MB)